Cargando…

Serum uric acid levels and risk of cardiovascular disease in type 2 diabetes: results from a cross-sectional study and Mendelian randomization analysis

AIMS: Serum uric acid (SUA) levels have been previously linked to a higher risk of cardiovascular disease (CVD) in individuals with type 2 diabetes (T2D) according to various observational studies. However, whether this association is causally linked or simply influenced by confounding factors is un...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ying, Feng, Jincheng, Zhang, Bo, Wu, Qiong, Zhou, Yongjie, He, Diao, Zheng, Daofeng, Yang, Jiayin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664243/
https://www.ncbi.nlm.nih.gov/pubmed/38027101
http://dx.doi.org/10.3389/fendo.2023.1251451
_version_ 1785138573647806464
author He, Ying
Feng, Jincheng
Zhang, Bo
Wu, Qiong
Zhou, Yongjie
He, Diao
Zheng, Daofeng
Yang, Jiayin
author_facet He, Ying
Feng, Jincheng
Zhang, Bo
Wu, Qiong
Zhou, Yongjie
He, Diao
Zheng, Daofeng
Yang, Jiayin
author_sort He, Ying
collection PubMed
description AIMS: Serum uric acid (SUA) levels have been previously linked to a higher risk of cardiovascular disease (CVD) in individuals with type 2 diabetes (T2D) according to various observational studies. However, whether this association is causally linked or simply influenced by confounding factors is unclear. Therefore, this study utilized Mendelian randomization (MR) analysis to explore the causality between SUA levels and the risk of CVD in individuals with T2D. METHODS: Our study cohort consisted of 5723 participants who were diagnosed with T2D in the National Health and Nutrition Examination Survey (NHANES) from 1999-2018. The study assessed the association between SUA levels and the risk of CVD using a multivariable logistic regression model. To further examine causality between SUA levels and CVD, a two-sample MR study was conducted utilizing genetic data from genome-wide association studies (GWAS) involving over 140,000 individuals. The main MR analysis employed the inverse-variance-weighted (IVW) method. Additionally, several sensitivity analyses were performed to evaluate the robustness and pleiotropy of the results. RESULTS: In the cross-sectional study, after multivariable adjustment, participants with SUA levels >6.7 mg/dL exhibited odds ratios (ORs) of 1.51 (95% CI: 1.01-2.26, p=0.049) for heart failure, 1.02 (95% CI: 0.69-1.50, p=0.937) for coronary heart disease, 1.36 (95% CI: 0.78-2.38, p=0.285) for angina, and 1.22 (95% CI: 0.80-1.85, p=0.355) for myocardial infarction when compared to participants with SUA levels ≤ 4.6 mg/dL. However, in the IVW analysis, no causality between SUA levels and the risk of heart failure was observed (OR = 1.03, 95% CI: 0.97-1.09, p = 0.293). The secondary analysis yielded similar results (OR = 1.05, 95% CI: 0.96-1.14, p = 0.299). The sensitivity analyses further supported our primary findings. CONCLUSION: Based on the MR study, we did not find supporting evidence for a causal association between SUA levels and the risk of heart failure.
format Online
Article
Text
id pubmed-10664243
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106642432023-01-01 Serum uric acid levels and risk of cardiovascular disease in type 2 diabetes: results from a cross-sectional study and Mendelian randomization analysis He, Ying Feng, Jincheng Zhang, Bo Wu, Qiong Zhou, Yongjie He, Diao Zheng, Daofeng Yang, Jiayin Front Endocrinol (Lausanne) Endocrinology AIMS: Serum uric acid (SUA) levels have been previously linked to a higher risk of cardiovascular disease (CVD) in individuals with type 2 diabetes (T2D) according to various observational studies. However, whether this association is causally linked or simply influenced by confounding factors is unclear. Therefore, this study utilized Mendelian randomization (MR) analysis to explore the causality between SUA levels and the risk of CVD in individuals with T2D. METHODS: Our study cohort consisted of 5723 participants who were diagnosed with T2D in the National Health and Nutrition Examination Survey (NHANES) from 1999-2018. The study assessed the association between SUA levels and the risk of CVD using a multivariable logistic regression model. To further examine causality between SUA levels and CVD, a two-sample MR study was conducted utilizing genetic data from genome-wide association studies (GWAS) involving over 140,000 individuals. The main MR analysis employed the inverse-variance-weighted (IVW) method. Additionally, several sensitivity analyses were performed to evaluate the robustness and pleiotropy of the results. RESULTS: In the cross-sectional study, after multivariable adjustment, participants with SUA levels >6.7 mg/dL exhibited odds ratios (ORs) of 1.51 (95% CI: 1.01-2.26, p=0.049) for heart failure, 1.02 (95% CI: 0.69-1.50, p=0.937) for coronary heart disease, 1.36 (95% CI: 0.78-2.38, p=0.285) for angina, and 1.22 (95% CI: 0.80-1.85, p=0.355) for myocardial infarction when compared to participants with SUA levels ≤ 4.6 mg/dL. However, in the IVW analysis, no causality between SUA levels and the risk of heart failure was observed (OR = 1.03, 95% CI: 0.97-1.09, p = 0.293). The secondary analysis yielded similar results (OR = 1.05, 95% CI: 0.96-1.14, p = 0.299). The sensitivity analyses further supported our primary findings. CONCLUSION: Based on the MR study, we did not find supporting evidence for a causal association between SUA levels and the risk of heart failure. Frontiers Media S.A. 2023-11-07 /pmc/articles/PMC10664243/ /pubmed/38027101 http://dx.doi.org/10.3389/fendo.2023.1251451 Text en Copyright © 2023 He, Feng, Zhang, Wu, Zhou, He, Zheng and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
He, Ying
Feng, Jincheng
Zhang, Bo
Wu, Qiong
Zhou, Yongjie
He, Diao
Zheng, Daofeng
Yang, Jiayin
Serum uric acid levels and risk of cardiovascular disease in type 2 diabetes: results from a cross-sectional study and Mendelian randomization analysis
title Serum uric acid levels and risk of cardiovascular disease in type 2 diabetes: results from a cross-sectional study and Mendelian randomization analysis
title_full Serum uric acid levels and risk of cardiovascular disease in type 2 diabetes: results from a cross-sectional study and Mendelian randomization analysis
title_fullStr Serum uric acid levels and risk of cardiovascular disease in type 2 diabetes: results from a cross-sectional study and Mendelian randomization analysis
title_full_unstemmed Serum uric acid levels and risk of cardiovascular disease in type 2 diabetes: results from a cross-sectional study and Mendelian randomization analysis
title_short Serum uric acid levels and risk of cardiovascular disease in type 2 diabetes: results from a cross-sectional study and Mendelian randomization analysis
title_sort serum uric acid levels and risk of cardiovascular disease in type 2 diabetes: results from a cross-sectional study and mendelian randomization analysis
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664243/
https://www.ncbi.nlm.nih.gov/pubmed/38027101
http://dx.doi.org/10.3389/fendo.2023.1251451
work_keys_str_mv AT heying serumuricacidlevelsandriskofcardiovasculardiseaseintype2diabetesresultsfromacrosssectionalstudyandmendelianrandomizationanalysis
AT fengjincheng serumuricacidlevelsandriskofcardiovasculardiseaseintype2diabetesresultsfromacrosssectionalstudyandmendelianrandomizationanalysis
AT zhangbo serumuricacidlevelsandriskofcardiovasculardiseaseintype2diabetesresultsfromacrosssectionalstudyandmendelianrandomizationanalysis
AT wuqiong serumuricacidlevelsandriskofcardiovasculardiseaseintype2diabetesresultsfromacrosssectionalstudyandmendelianrandomizationanalysis
AT zhouyongjie serumuricacidlevelsandriskofcardiovasculardiseaseintype2diabetesresultsfromacrosssectionalstudyandmendelianrandomizationanalysis
AT hediao serumuricacidlevelsandriskofcardiovasculardiseaseintype2diabetesresultsfromacrosssectionalstudyandmendelianrandomizationanalysis
AT zhengdaofeng serumuricacidlevelsandriskofcardiovasculardiseaseintype2diabetesresultsfromacrosssectionalstudyandmendelianrandomizationanalysis
AT yangjiayin serumuricacidlevelsandriskofcardiovasculardiseaseintype2diabetesresultsfromacrosssectionalstudyandmendelianrandomizationanalysis